Diabetes linked to lung cancer in postmenopausal women

May 30, 2012
Diabetes linked to lung cancer in postmenopausal women
Postmenopausal women with diabetes are at a significantly higher risk of developing lung cancer, particularly if they require insulin therapy, according to research published online May 22 in Diabetes Care.

(HealthDay) -- Postmenopausal women with diabetes are at a significantly higher risk of developing lung cancer, particularly if they require insulin therapy, according to research published online May 22 in Diabetes Care.

Juhua Luo, Ph.D., of West Virginia University in Morgantown, and colleagues utilized data from the Women's Health Initiative study involving a total of 145,765 postmenopausal women aged 50 to 79 years, of whom 8,154 had diabetes, who were followed for an average of 11 years. A total of 2,257 cases of were diagnosed.

The researchers found that postmenopausal women with self-reported treated diabetes were 27 percent more likely to be diagnosed with lung cancer compared with women without diabetes. Furthermore, postmenopausal women with diabetes who required were 71 percent more likely to be diagnosed with lung cancer. No association between lung cancer risk and either duration of diabetes or untreated diabetes was observed.

"In this large prospective study in , women with treated diabetes, especially those requiring insulin, had significantly higher risk of lung cancer," the authors write. "The risk of lung cancer did not differ significantly by duration of diabetes."

Explore further: Thiazolidinediones tied to lower cancer risk in diabetes patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Lung cancer patients with diabetes show prolonged survival

October 17, 2011

Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a Norwegian study published in the November issue of the Journal of Thoracic Oncology, the official publication of the International ...

Recommended for you

New blood test may better predict gestational diabetes

April 27, 2017

A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity ...

Post-biotics may help shield obese from diabetes

April 20, 2017

You've heard of pre-biotics and pro-biotics, but now you'll be hearing a lot more about post-biotics. Researchers at McMaster University have begun to identify how post-biotics, or the by-products of bacteria, lower blood ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.